ABOUT THE 12th ANNUAL EUROPEAN LIFE SCIENCES CEO FORUM
Back for its 12th Annual edition, this global bio-pharma industry forum addresses through its conference programme the main challenges for 2019 in investment, partnering and alliance management. Key players contribute their insights in panels which cover the macro picture as well as innovation in the different therapeutic sectors. The forum also features keynote speeches by KOL and about 60 selected corporate presentations from established (public and private) and emerging biotechs seeking to promote investment and partnering opportunities. We expect over 350 delegates to attend the event. The forum will provide a number of networking opportunities via our online one-to-one meeting system which allows you to pre-book meetings with all the attendees at the dedicated meeting facilities. We anticipate more than 1500 face-to-face meetings to take place throughout 2 days.
This year, following our conference, in the afternoon of the 26th we will also host the 1st GoforIsrael Life Sciences Conference. We will bring together leading global investors and Israel’s best opportunities from the Life Sciences industry, addressing current issues related to raising capital and establishing strategic alliances in Europe. The companies taking part in the GoforIsrael part of the Sachs ELSCEO forum will be leading Israeli companies in the fields of MedTech, Biotech, Pharmaceuticals, Diagnostics, and Digital Health.
Plenary Sessions include:
China-Europe Partnering & Investment Panel
Early Stage Investor Roundtable
“Latest Trends in Fund Raising & Investment” – Private Equity & VC Panel
Pharma DealMakers Roundtable
“Prospects for 2019”- Global Biopharma Industry Review Panel
Rising Stars: Start-Up Showcase
Therapeutic Panels include:
Advances in C&G Therapies Panel
Autoimmune & Inflammatory Diseases Panel
Neuroscience BD&L Panel
Platform Technologies & Novel Therapeutics Panel
Oncology Advanced Therapies and Diagnostics Panel
Oncology DealMaking Panel
Confirmed Keynotes include:
The Scientific & Investment Potential of Cannabinoids by Jim DeMesa, CEO, Emerald Health Pharmaceuticals
Metriopharm: Considering an IPO “How to best prepare yourself for this enabling step?” by Dr. Søren Bjønness, Director – Swiss Representative, EURONEXT
Wolfgang Brysch, Founder and Chief Executive Officer, MetrioPharm AG
Yochi Slonim, Co-Founder, CEO, Anima Biotech, Inc.
And more TBA...
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business. Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering.
Make connections, engage in conversation, and exchange knowledge with key decision-makers eager to learn how your company can help them meet their goals and achieve their mission. Exhibiting at 12th Annual European Life Sciences CEO Forum & Exhibition is an effective way to gain leads, introduce new products and services, expand sales, and build relationships. Exhibition space is very limited - express your interest to secure the area.
Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market. Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.
To learn more about presenting, exhibition or sponsorship opportunities, please contact: Silvia Kar on + 44 (0)203 463 4890 or by email: Silvia.
FINANCIAL, ADVISORY, INVESTORS IN 2019: AbbVie Ventures Abingworth LLP ACXIT Capital Management GmbH aescuvest international GmbH Alpha Omega LLC Andera Partners Arix Bioscience Plc. Avego Healthcare Capital Bay City Capital, LLC BB Biotech Ventures BERNINA BioInvest Ltd BioBac BioValley Basel Business Angels Club BioMedPartners AG BioSeed Capital BioStart Consulting GmbH Böhler Life Science Advice Bryan, Garnier & Co Capital Grand Est Capricorn Venture Partners NV Cederberg GmbH Convergence Partners AG Creathor Ventures Cukierman & Co. Life Sciences E.Gutzwiller & Cie, Banquiers EIT Health e.V. Ernst & Young AG Forbion Capital Partners Fraser Finance Fresenius Medical Care Ventures GmbH Gilde Healthcare Partners Gimv